Clinicians

Let’s create a world where
stage is just a number.

SCINTIXTM therapy from RefleXion is a breakthrough technology creating a
new option for patients - even those with metastatic disease.

See Clinical Evidence

Scintix logo

For the first time ever, SCINTIX biology-guided radiotherapy uses the emissions from the cancer itself for live targeting of tumors at any stage.

SCINTIX THERAPY

Learn more about RefleXion’s breakthrough technology.

SCINTIX Therapy uses Emissions to Track and Treat in Real Time.

See how SCINTIX Therapy uses cancer’s own emissions as a means to guide radiotherapy in real time.

SCINTIX Biology-guided Radiotherapy for Metastatic Disease

Learn how RefleXion BgRT is being designed from the ground up to treat multiple tumors in parallel during a single session.

The Potential of PET Tracers

See how RefleXion SCINTIX Biology-guided Radiotherapy unlocks the potential of PET tracers – now and in the future.

RefleXion X1 Machine Overview

Learn more about RefleXion technology and what makes our machine unique.

RADIOTRACERS

SAME RADIOTRACERS, NEW ROLE

Powered by the rapidly expanding universe of radiopharmaceuticals, the RefleXion® X1 with SCINTIX technology uses PET emissions for live targeting of tumors at any stage. Only SCINTIX therapy will leverage disease-specific radiotracers as they become available.

DUAL MODALITY PLATFORM

ONE MACHINE.
MULTIPLE MODALITIES.

The RefleXion X1 is designed to deliver SCINTIX therapy along with industry-leading CT-guided IMRT and SBRT. Equipped with fan-beam kVCT imaging, RefleXion aims to reduce toxicities from radiotherapy while delivering a powerful blow to the target.

PATIENT POPULATIONS

PICK A NUMBER,
ONE THROUGH FOUR

SCINTIX biology-guided radiotherapy makes definitive radiotherapy an option for patients with any stage of cancer. Our breakthrough technology expands treatment to hundreds of thousands of patients across the U.S.

MOVING TUMORS

MOTION. MANAGED.

Finally, SCINTIX therapy solves the conundrum of tumor tracking by using PET emissions to deliver live targeting information continuously during treatment. This approach reduces the need for motion management techniques such as gating or implanted fiducials and may result in lower toxicity to healthy tissue.

Feedback
and
Inquiries.

Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up